BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31735064)

  • 1. (-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia.
    Fang W; Peng ZL; Dai YJ; Wang DL; Huang P; Huang HP
    Drug Deliv; 2019 Dec; 26(1):1058-1067. PubMed ID: 31735064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage.
    Avadhani KS; Manikkath J; Tiwari M; Chandrasekhar M; Godavarthi A; Vidya SM; Hariharapura RC; Kalthur G; Udupa N; Mutalik S
    Drug Deliv; 2017 Nov; 24(1):61-74. PubMed ID: 28155509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
    Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigallocatechin Gallate/Layered Double Hydroxide Nanohybrids: Preparation, Characterization, and In Vitro Anti-Tumor Study.
    Shafiei SS; Solati-Hashjin M; Samadikuchaksaraei A; Kalantarinejad R; Asadi-Eydivand M; Abu Osman NA
    PLoS One; 2015; 10(8):e0136530. PubMed ID: 26317853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigallocatechin gallate, ellagic acid, and rosmarinic acid perturb dNTP pools and inhibit de novo DNA synthesis and proliferation of human HL-60 promyelocytic leukemia cells: Synergism with arabinofuranosylcytosine.
    Saiko P; Steinmann MT; Schuster H; Graser G; Bressler S; Giessrigl B; Lackner A; Grusch M; Krupitza G; Bago-Horvath Z; Jaeger W; Fritzer-Szekeres M; Szekeres T
    Phytomedicine; 2015 Jan; 22(1):213-22. PubMed ID: 25636891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers.
    Hajipour H; Hamishehkar H; Nazari Soltan Ahmad S; Barghi S; Maroufi NF; Taheri RA
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):283-292. PubMed ID: 29310467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines.
    Silva AM; Martins-Gomes C; Fangueiro JF; Andreani T; Souto EB
    Pharm Dev Technol; 2019 Dec; 24(10):1243-1249. PubMed ID: 31437118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preparation and characterization of gold-conjugated polyphenol nanoparticles as a novel delivery system.
    Hsieh DS; Lu HC; Chen CC; Wu CJ; Yeh MK
    Int J Nanomedicine; 2012; 7():1623-33. PubMed ID: 22615529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer.
    Radhakrishnan R; Kulhari H; Pooja D; Gudem S; Bhargava S; Shukla R; Sistla R
    Chem Phys Lipids; 2016 Jun; 198():51-60. PubMed ID: 27234272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target challenging-cancer drug delivery to gastric cancer tissues with a fucose graft epigallocatechin-3-gallate-gold particles nanocomposite approach.
    Yuan X; He Y; Zhou G; Li X; Feng A; Zheng W
    J Photochem Photobiol B; 2018 Jun; 183():147-153. PubMed ID: 29705507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
    Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
    Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
    Singh M; Bhatnagar P; Mishra S; Kumar P; Shukla Y; Gupta KC
    Int J Nanomedicine; 2015; 10():6789-809. PubMed ID: 26586942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigallocatechin-3-gallate enhances differentiation of acute promyelocytic leukemia cells via inhibition of PML-RARα and HDAC1.
    Moradzadeh M; Roustazadeh A; Tabarraei A; Erfanian S; Sahebkar A
    Phytother Res; 2018 Mar; 32(3):471-479. PubMed ID: 29193405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells.
    Borutinskaitė V; Virkšaitė A; Gudelytė G; Navakauskienė R
    Leuk Lymphoma; 2018 Feb; 59(2):469-478. PubMed ID: 28641467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in growth suppression and apoptosis induction of EGCG and EGC on human promyelocytic leukemia HL-60 cells.
    Han DH; Kim JH
    Arch Pharm Res; 2009 Apr; 32(4):543-7. PubMed ID: 19407972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer.
    Tang P; Sun Q; Yang H; Tang B; Pu H; Li H
    Int J Pharm; 2018 Jul; 545(1-2):74-83. PubMed ID: 29715531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of oral nanovesicle in-situ gel based on Epigallocatechin gallate phospholipid complex: Application in dental anti-caries.
    Xu X; Dai Z; Zhang Z; Kou X; You X; Sun H; Guo H; Liu M; Zhu H
    Eur J Pharmacol; 2021 Apr; 897():173951. PubMed ID: 33607105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity.
    Bae KH; Tan S; Yamashita A; Ang WX; Gao SJ; Wang S; Chung JE; Kurisawa M
    Biomaterials; 2017 Dec; 148():41-53. PubMed ID: 28961534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer.
    Zhang L; Chen W; Tu G; Chen X; Lu Y; Wu L; Zheng D
    Int J Nanomedicine; 2020; 15():4417-4429. PubMed ID: 32606686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
    Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
    Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.